Literature DB >> 2128295

Immunology of celiac disease: tissue and species specificity of endomysial and reticulin antibodies.

J E Valeski1, V Kumar, E H Beutner, A Lerner, T P Chorzelski.   

Abstract

Patients with celiac disease and dermatitis herpetiformis have circulating antibodies to reticulin and endomysium, the 'extracellular matrix' components as defined by their detection on rodent and primate tissues, respectively. Because both types of antibodies occur in both forms of gluten-sensitive enteropathy, studies were conducted to determine if the two types of antibodies can be distinguished by species and organ specificity. The results of these studies indicate that distinct endomysium-specific and reticulin-specific antibodies can be found and that these differ in their species specificity; i.e., endomysium antigen occurs in primate and not in rodent tissues while the reticulin antigen occurs in rodent and not in primate tissues. However, the activity of both endomysium and reticulin antibodies demonstrates similar tissue distribution, in that both react to antigens associated with gastrointestinal smooth muscles, peritubular and periglomerular areas of the kidney, and sinusoidal and periportal areas of the liver. Also, both antigens seem to be present in sheep and goat tissue. These studies indicate that the antigens reactive with endomysial antibodies are distinct from those reactive with reticulin antibodies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2128295     DOI: 10.1159/000235271

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  7 in total

1.  Increased prevalence of autoantibodies in celiac disease.

Authors:  A Lerner; M Blank; N Lahat; Y Shoenfeld
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

2.  Immunological diagnosis of childhood coeliac disease: comparison between antigliadin, antireticulin and antiendomysial antibodies.

Authors:  A Lerner; V Kumar; T C Iancu
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

3.  Gliadin peptides activate blood monocytes from patients with celiac disease.

Authors:  Jana Cinova; Lenka Palová-Jelínková; Lesley E Smythies; Marie Cerná; Barbara Pecharová; Milos Dvorák; Pavel Fruhauf; Helena Tlaskalová-Hogenová; Phillip D Smith; Ludmila Tucková
Journal:  J Clin Immunol       Date:  2007-01-27       Impact factor: 8.317

4.  IgA antibodies to jejunum. Specific immunity directed against target organ of gluten-sensitive enteropathy.

Authors:  U Volta; N Molinaro; D Fratangelo; F B Bianchi
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

5.  Development of an immunocapture method for measuring IgA antibodies to tissue transglutaminase in the sera of patients with coeliac disease.

Authors:  S El Alaoui; C Gresti
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

6.  Endomysium antibodies in coeliac disease: an improved method.

Authors:  B Ladinser; E Rossipal; K Pittschieler
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

7.  Missing endomysial and reticulin binding of coeliac antibodies in transglutaminase 2 knockout tissues.

Authors:  I R Korponay-Szabó; K Laurila; Z Szondy; T Halttunen; Z Szalai; I Dahlbom; I Rantala; J B Kovács; L Fésüs; M Mäki
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.